News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PSI CRO Launches A Global Phase 3 Rare Disease Trial


7/22/2014 11:09:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ZUG, Switzerland--(BUSINESS WIRE)--

PSI CRO, a full-service contract research organization, announced today the launch of a new global study in Polycythemia vera in collaboration with AOP Orphan. PSI is setting up this 100-patient open-label, multicenter study at 45 sites across 13 countries globally.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES